首页 > 最新文献

World Journal of OtorhinolaryngologyHead and Neck Surgery最新文献

英文 中文
Using injectable fillers for chin and jawline rejuvenation. 使用注射填充剂使下巴和下颌角年轻化。
Q2 Medicine Pub Date : 2023-03-28 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.93
Beatrice C Go, Ariel S Frost, Oren Friedman

Objective: As the population ages, facial plastic providers must remain aware of the treatments to prevent and reverse the external signs of aging. In the mandibular region, skin laxity and soft tissue sagging in the jawline may lead to jowling and chin ptosis along with reduced chin projection. While surgical procedures, including chin implantation, may be performed, nonsurgical procedures are becoming increasingly popular due to their temporary, noninvasive, yet effective methods. This review covers the use of hyaluronic acid, calcium hydroxylapatite, poly-l-lactic acid, and polymethyl methacrylate in the jawline.

Methods: PubMed was searched for data on the mechanism of action, pertinent anatomy, indications, contraindications, technique, and evidence supporting the safety and efficacy of the fillers.

Results: There are a wide variety of fillers available for use in the lower face with unique characteristics and application methods. While the advantages of injectable fillers include relatively affordable cost, minimal patient discomfort, and limited recovery times, taking measures to prevent short- and long-term complications is necessary for optimal results.

Conclusions: Understanding the benefits and limitations of injectable fillers in the jawline can help providers appropriately counsel and treat patients.

目的:随着人口老龄化的加剧,面部整形医生必须了解预防和扭转外部衰老迹象的治疗方法。在下颌区域,下颌角的皮肤松弛和软组织下垂可能会导致下颌角下垂、下巴下垂以及下巴凸出减少。虽然可以进行包括隆下巴在内的手术治疗,但非手术治疗因其临时、无创、有效的方法而越来越受欢迎。本综述涵盖了透明质酸、羟基磷灰石钙、聚乳酸和聚甲基丙烯酸甲酯在下颌角的应用:方法:在 PubMed 上搜索有关填充剂的作用机制、相关解剖学、适应症、禁忌症、技术以及支持其安全性和有效性的证据:可用于下面部的填充剂种类繁多,各有特点和应用方法。虽然注射填充剂的优点包括成本相对低廉、患者不适感极小、恢复时间有限,但要获得最佳效果,必须采取措施预防短期和长期并发症:了解下颌角注射填充剂的优点和局限性有助于医疗人员为患者提供适当的咨询和治疗。
{"title":"Using injectable fillers for chin and jawline rejuvenation.","authors":"Beatrice C Go, Ariel S Frost, Oren Friedman","doi":"10.1002/wjo2.93","DOIUrl":"10.1002/wjo2.93","url":null,"abstract":"<p><strong>Objective: </strong>As the population ages, facial plastic providers must remain aware of the treatments to prevent and reverse the external signs of aging. In the mandibular region, skin laxity and soft tissue sagging in the jawline may lead to jowling and chin ptosis along with reduced chin projection. While surgical procedures, including chin implantation, may be performed, nonsurgical procedures are becoming increasingly popular due to their temporary, noninvasive, yet effective methods. This review covers the use of hyaluronic acid, calcium hydroxylapatite, poly-l-lactic acid, and polymethyl methacrylate in the jawline.</p><p><strong>Methods: </strong>PubMed was searched for data on the mechanism of action, pertinent anatomy, indications, contraindications, technique, and evidence supporting the safety and efficacy of the fillers.</p><p><strong>Results: </strong>There are a wide variety of fillers available for use in the lower face with unique characteristics and application methods. While the advantages of injectable fillers include relatively affordable cost, minimal patient discomfort, and limited recovery times, taking measures to prevent short- and long-term complications is necessary for optimal results.</p><p><strong>Conclusions: </strong>Understanding the benefits and limitations of injectable fillers in the jawline can help providers appropriately counsel and treat patients.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"131-137"},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b9/33/WJO2-9-131.PMC10296042.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Member List of the Second Editorial Board of World Journal of Otorhinolaryngology‐Head and Neck Surgery 《世界耳鼻咽喉头颈外科杂志》第二届编委会成员名单
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1002/wjo2.98
World Journal of Otorhinolaryngology - Head and Neck SurgeryVolume 9, Issue 1 p. 105-105 MEMBER LIST OF THE FIRST EDITORIAL BOARD OF WORLD JOURNAL OF OTORHINOLARYNGOLOGY-HEAD AND NECK SURGERYOpen Access Member List of the First Editorial Board of World Journal of Otorhinolaryngology-Head and Neck Surgery First published: 28 March 2023 https://doi.org/10.1002/wjo2.98AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume9, Issue1March 2023Pages 105-105 RelatedInformation
《世界耳鼻咽喉头颈外科杂志》第9卷第1期第105-105页《世界耳鼻咽喉头颈外科杂志》第一编委会成员名单2023年3月28日https://doi.org/10.1002/wjo2.98AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare全文accessShare全文accessShare请查看我们的使用条款和条件,并勾选下面的复选框共享文章的全文版本。我已经阅读并接受了Wiley在线图书馆使用共享链接的条款和条件,请使用下面的链接与您的朋友和同事分享本文的全文版本。学习更多的知识。复制链接分享链接分享到facebooktwitterlinkedinreddit微信本文没有摘要。第9卷第1期2023年3月页105-105
{"title":"Member List of the Second Editorial Board of World Journal of Otorhinolaryngology‐Head and Neck Surgery","authors":"","doi":"10.1002/wjo2.98","DOIUrl":"https://doi.org/10.1002/wjo2.98","url":null,"abstract":"World Journal of Otorhinolaryngology - Head and Neck SurgeryVolume 9, Issue 1 p. 105-105 MEMBER LIST OF THE FIRST EDITORIAL BOARD OF WORLD JOURNAL OF OTORHINOLARYNGOLOGY-HEAD AND NECK SURGERYOpen Access Member List of the First Editorial Board of World Journal of Otorhinolaryngology-Head and Neck Surgery First published: 28 March 2023 https://doi.org/10.1002/wjo2.98AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume9, Issue1March 2023Pages 105-105 RelatedInformation","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"236 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135289975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Guidelines. 作者指导方针。
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1002/wjo2.97
{"title":"Author Guidelines.","authors":"","doi":"10.1002/wjo2.97","DOIUrl":"https://doi.org/10.1002/wjo2.97","url":null,"abstract":"","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 1","pages":"97-104"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050960/pdf/WJO2-9-97.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9588145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of age and sex in botulinum neurotoxin dosing for adductor spasmodic dysphonia. 肉毒杆菌神经毒素治疗内收肌痉挛性发音障碍的剂量与年龄和性别有关。
Q2 Medicine Pub Date : 2023-01-29 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.88
Richard Heyes, Charles H Adler, Nan Zhang, David G Lott, Stephen F Bansberg

Objectives: This study aims to analyze the impact of age and sex on botulinum neurotoxin (BoNT-A) dosing and outcomes in adductor spasmodic dysphonia (AdSD).

Methods: A database review of all spasmodic dysphonia patients treated with BoNT from 1989 to 2018 at the Mayo Clinic in Arizona was performed. Only patients who had received ≥4 injections of BoNT-A for AdSD were included. Patients were divided into two cohorts to analyze age, with an age of first treatment cutoff of 60 years. Patients were divided into male and female cohorts to analyze sex.

Results: The final analysis included 398 patients. The mean dose of BoNT-A per treatment was significantly higher in the younger cohort (4.4 vs. 3.9 units, p = 0.048). The mean maximal benefit was similar (72% vs. 70%, p = 0.48); however, the mean length of benefit was significantly shorter in younger patients (3.0 vs. 3.6 months, p < 0.01). The mean BoNT-A dose was significantly higher in the female cohort (4.2 vs. 3.6 units, p = 0.02). The mean maximal benefit was similar (69% vs. 75%, p = 0.58), as was the mean length of benefit (3.2 vs. 3.5 months, p = 0.11).

Conclusions: This study suggests that age and sex influence BoNT-A dosing and outcomes in AdSD.

研究目的本研究旨在分析年龄和性别对肉毒杆菌神经毒素(BoNT-A)剂量和内收肌痉挛性发音障碍(AdSD)治疗效果的影响:对亚利桑那州梅奥诊所 1989 年至 2018 年期间接受 BoNT 治疗的所有痉挛性发音障碍患者进行了数据库回顾。仅纳入接受过≥4次BoNT-A治疗的患者。根据年龄将患者分为两个队列进行分析,首次治疗的截止年龄为 60 岁。分析性别时,将患者分为男性和女性两组:最终分析包括 398 名患者。年轻组群每次治疗的 BoNT-A 平均剂量明显更高(4.4 单位对 3.9 单位,P = 0.048)。平均最大获益时间相似(72% 对 70%,P = 0.48);但年轻患者的平均获益时间明显较短(3.0 个月对 3.6 个月,P = 0.02)。平均最大获益率(69% vs. 75%,p = 0.58)和平均获益时间(3.2 vs. 3.5个月,p = 0.11)相似:本研究表明,年龄和性别会影响 BoNT-A 的剂量和 AdSD 的治疗效果。
{"title":"Significance of age and sex in botulinum neurotoxin dosing for adductor spasmodic dysphonia.","authors":"Richard Heyes, Charles H Adler, Nan Zhang, David G Lott, Stephen F Bansberg","doi":"10.1002/wjo2.88","DOIUrl":"10.1002/wjo2.88","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to analyze the impact of age and sex on botulinum neurotoxin (BoNT-A) dosing and outcomes in adductor spasmodic dysphonia (AdSD).</p><p><strong>Methods: </strong>A database review of all spasmodic dysphonia patients treated with BoNT from 1989 to 2018 at the Mayo Clinic in Arizona was performed. Only patients who had received ≥4 injections of BoNT-A for AdSD were included. Patients were divided into two cohorts to analyze age, with an age of first treatment cutoff of 60 years. Patients were divided into male and female cohorts to analyze sex.</p><p><strong>Results: </strong>The final analysis included 398 patients. The mean dose of BoNT-A per treatment was significantly higher in the younger cohort (4.4 vs. 3.9 units, <i>p</i> = 0.048). The mean maximal benefit was similar (72% vs. 70%, <i>p</i> = 0.48); however, the mean length of benefit was significantly shorter in younger patients (3.0 vs. 3.6 months, <i>p</i> < 0.01). The mean BoNT-A dose was significantly higher in the female cohort (4.2 vs. 3.6 units, <i>p</i> = 0.02). The mean maximal benefit was similar (69% vs. 75%, <i>p</i> = 0.58), as was the mean length of benefit (3.2 vs. 3.5 months, <i>p</i> = 0.11).</p><p><strong>Conclusions: </strong>This study suggests that age and sex influence BoNT-A dosing and outcomes in AdSD.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"168-173"},"PeriodicalIF":0.0,"publicationDate":"2023-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective analysis of pain and opioid usage in head and neck free flap reconstruction. 头颈部游离皮瓣重建术中疼痛和阿片类药物使用情况的回顾性分析。
Q2 Medicine Pub Date : 2023-01-12 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.87
Parhom Towfighi, Alison Hill, Jason R Crossley, Amanda Walsh, James A Leonard, Jonathan P Giurintano, Matthew L Pierce, Michael J Reilly

Objectives: Investigate opioid usage and postoperative pain in patients undergoing head and neck free flap surgery.

Methods: A retrospective review of 100 consecutive patients undergoing head and neck free flap reconstruction at two academic centers was performed. Data captured included demographics, postoperative inpatient pain, pain at postoperative visits, morphine equivalent doses (MEDs) administration, medication history, and comorbidities. Data were analyzed using regression models, χ 2 tests, and student's t-tests.

Results: Seventy-three percent of patients were discharged with opioid medication, with over half (53.4%) continuing to take opioids at their second postoperative visit, and over one-third (34.2%) continuing to take them around 4-month postoperatively. One out of every five (20.3%) opioid-naïve patients chronically took opioids postoperatively. There was a poor association between inpatient postoperative pain scores and daily MEDs administered (R 2 = 0.13, 0.17, and 0.22 in postoperative Days 3, 5, and 7, respectively). Neither preoperative radiotherapy nor postoperative complications were associated with an increase in opioid usage.

Conclusions: For patients undergoing head and neck free flap operations, opioid medications are commonly used for postoperative analgesia. This practice may increase the chance an opioid-naïve patient uses opioids chronically. We found a poor association between MEDs administered and patient-reported pain scores, which suggests that standardized protocols aimed at optimizing analgesia while reducing opioid administration may be warranted. Level of Evidence: 3 (Retrospective cohort study).

目的:调查头颈部游离皮瓣手术患者阿片类药物的使用情况和术后疼痛:调查头颈部游离皮瓣手术患者阿片类药物的使用情况和术后疼痛:方法:对两家学术中心连续接受头颈部游离皮瓣重建手术的 100 名患者进行回顾性研究。采集的数据包括人口统计学、术后住院疼痛、术后就诊疼痛、吗啡当量剂量(MED)用药、用药史和合并症。数据分析采用回归模型、χ 2 检验和学生 t 检验:73%的患者出院时服用了阿片类药物,超过一半(53.4%)的患者在术后第二次就诊时继续服用阿片类药物,超过三分之一(34.2%)的患者在术后4个月左右继续服用阿片类药物。每五名阿片类药物无效患者中就有一人(20.3%)在术后长期服用阿片类药物。住院患者的术后疼痛评分与每日MEDs用量之间的关系不大(术后第3、5和7天的R 2分别为0.13、0.17和0.22)。术前放疗和术后并发症都与阿片类药物用量的增加无关:结论:对于接受头颈部游离皮瓣手术的患者,阿片类药物通常用于术后镇痛。这种做法可能会增加阿片类药物过敏患者长期使用阿片类药物的几率。我们发现所使用的 MEDs 与患者报告的疼痛评分之间的关系不大,这表明有必要制定标准化方案,在减少阿片类药物用量的同时优化镇痛效果。证据等级:3(回顾性队列研究)。
{"title":"A retrospective analysis of pain and opioid usage in head and neck free flap reconstruction.","authors":"Parhom Towfighi, Alison Hill, Jason R Crossley, Amanda Walsh, James A Leonard, Jonathan P Giurintano, Matthew L Pierce, Michael J Reilly","doi":"10.1002/wjo2.87","DOIUrl":"10.1002/wjo2.87","url":null,"abstract":"<p><strong>Objectives: </strong>Investigate opioid usage and postoperative pain in patients undergoing head and neck free flap surgery.</p><p><strong>Methods: </strong>A retrospective review of 100 consecutive patients undergoing head and neck free flap reconstruction at two academic centers was performed. Data captured included demographics, postoperative inpatient pain, pain at postoperative visits, morphine equivalent doses (MEDs) administration, medication history, and comorbidities. Data were analyzed using regression models, <i>χ</i> <sup>2</sup> tests, and student's <i>t</i>-tests.</p><p><strong>Results: </strong>Seventy-three percent of patients were discharged with opioid medication, with over half (53.4%) continuing to take opioids at their second postoperative visit, and over one-third (34.2%) continuing to take them around 4-month postoperatively. One out of every five (20.3%) opioid-naïve patients chronically took opioids postoperatively. There was a poor association between inpatient postoperative pain scores and daily MEDs administered (<i>R</i> <sup>2</sup> = 0.13, 0.17, and 0.22 in postoperative Days 3, 5, and 7, respectively). Neither preoperative radiotherapy nor postoperative complications were associated with an increase in opioid usage.</p><p><strong>Conclusions: </strong>For patients undergoing head and neck free flap operations, opioid medications are commonly used for postoperative analgesia. This practice may increase the chance an opioid-naïve patient uses opioids chronically. We found a poor association between MEDs administered and patient-reported pain scores, which suggests that standardized protocols aimed at optimizing analgesia while reducing opioid administration may be warranted. <b>Level of Evidence:</b> 3 (Retrospective cohort study).</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"153-159"},"PeriodicalIF":0.0,"publicationDate":"2023-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/c2/WJO2-9-153.PMC10296052.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9714524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current practices regarding middle turbinate resection among otolaryngologists. 耳鼻喉科医生目前对中鼻甲切除术的做法。
Q2 Medicine Pub Date : 2022-11-23 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.84
Andrea Ziegler, Monica Patadia, Chirag Patel

Objectives: Resection of the middle turbinate (MT) during endoscopic sinus surgery (ESS) has been a controversial topic among otolaryngologists for many years. Some studies advocate resection and have shown improved outcomes postoperatively, while studies favoring preservation show a decreased incidence of postoperative complications. The current practice pattern regarding this subject is unknown. The goal of this study was to learn the current practice of MT resection during ESS among otolaryngologists.

Method: We performed an electronic anonymous survey of practicing otolaryngologists.

Results: We found that the majority of the 252 responders stated that they will perform an MT resection in certain clinical situations, while there is a small subset that advocates never resecting the MT for inflammatory sinus disease (n = 6, 2.4%). Participants were significantly more likely to perform MT resection in patients undergoing revision compared to primary ESS for all conditions included. The complication of greatest concern among participants was iatrogenic frontal sinus obstruction, while empty nose was of the least concern. The majority of participants responded that MT resection was of extreme or moderate benefit for improved visualization and drug delivery postoperatively. When compared to general otolaryngologists, fellowship-trained rhinologists were less concerned about potential complications following MT resection and were more likely to perceive an extreme or moderate benefit from turbinate resection postoperatively.

Conclusion: There remains debate over MT resection among otolaryngologists, but the results of this study show that the majority of participating otolaryngologists will perform a resection in certain clinical situations.

目的:多年来,在内窥镜鼻窦手术(ESS)中切除中鼻甲(MT)一直是耳鼻喉科医生争议的话题。一些研究主张切除中鼻甲,并显示术后效果有所改善,而主张保留中鼻甲的研究则显示术后并发症的发生率有所降低。目前有关这一问题的实践模式尚不清楚。本研究的目的是了解目前耳鼻喉科医生在 ESS 期间切除 MT 的做法:方法:我们对执业耳鼻喉科医生进行了电子匿名调查:我们发现,在 252 位回复者中,大多数人表示他们会在某些临床情况下实施 MT 切除术,而有一小部分人则主张对炎症性鼻窦疾病从不实施 MT 切除术(n = 6,2.4%)。在所有病症中,与初诊ESS相比,参与者更倾向于为接受翻修手术的患者实施MT切除术。参与者最担心的并发症是先天性额窦阻塞,而最不担心的是空鼻。大多数参与者认为 MT 切除术对改善术后可视性和药物输送有极大或中等程度的益处。与普通耳鼻喉科医生相比,接受过研究培训的鼻科医生对 MT 切除术后潜在并发症的担忧较少,更倾向于认为鼻甲切除术后会带来极大或中等程度的益处:结论:耳鼻喉科医生对鼻甲切除术仍存在争议,但本研究结果表明,大多数参与研究的耳鼻喉科医生会在某些临床情况下实施鼻甲切除术。
{"title":"Current practices regarding middle turbinate resection among otolaryngologists.","authors":"Andrea Ziegler, Monica Patadia, Chirag Patel","doi":"10.1002/wjo2.84","DOIUrl":"10.1002/wjo2.84","url":null,"abstract":"<p><strong>Objectives: </strong>Resection of the middle turbinate (MT) during endoscopic sinus surgery (ESS) has been a controversial topic among otolaryngologists for many years. Some studies advocate resection and have shown improved outcomes postoperatively, while studies favoring preservation show a decreased incidence of postoperative complications. The current practice pattern regarding this subject is unknown. The goal of this study was to learn the current practice of MT resection during ESS among otolaryngologists.</p><p><strong>Method: </strong>We performed an electronic anonymous survey of practicing otolaryngologists.</p><p><strong>Results: </strong>We found that the majority of the 252 responders stated that they will perform an MT resection in certain clinical situations, while there is a small subset that advocates never resecting the MT for inflammatory sinus disease (<i>n</i> = 6, 2.4%). Participants were significantly more likely to perform MT resection in patients undergoing revision compared to primary ESS for all conditions included. The complication of greatest concern among participants was iatrogenic frontal sinus obstruction, while empty nose was of the least concern. The majority of participants responded that MT resection was of extreme or moderate benefit for improved visualization and drug delivery postoperatively. When compared to general otolaryngologists, fellowship-trained rhinologists were less concerned about potential complications following MT resection and were more likely to perceive an extreme or moderate benefit from turbinate resection postoperatively.</p><p><strong>Conclusion: </strong>There remains debate over MT resection among otolaryngologists, but the results of this study show that the majority of participating otolaryngologists will perform a resection in certain clinical situations.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"183-188"},"PeriodicalIF":0.0,"publicationDate":"2022-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1e/34/WJO2-9-183.PMC10296039.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9735386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carcinosarcoma of the nasal cavity and paranasal sinuses: Review of the national cancer database. 鼻腔和副鼻窦癌:国家癌症数据库回顾。
Q2 Medicine Pub Date : 2022-10-27 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.82
Jacob C Harris, Jacob G Eide, Rijul S Kshirsagar, Jason A Brant, James N Palmer, Nithin D Adappa

Background: Carcinosarcomas are rare, aggressive malignancies that can arise in the nasal cavity and paranasal sinuses. There are limited outcome data available. Accordingly, we sought to use the National Cancer Database (NCDB) to characterize patient demographics and outcomes.

Method: A retrospective analysis of the NCDB from 2004 to 2016 for patients with sinonasal carcinosarcoma was conducted.

Results: Thirty patients were included. The patients were predominantly male (n = 20), white (n = 23), and privately insured (n = 15), with an average age of 62.4 years. The nasal cavity was the most common subsite (n = 14), followed by the maxillary sinus (n = 8). Most patient were treated with surgery followed by radiation (n = 23), with the remaining undergoing surgery alone (n = 4), radiation alone (n = 2), or no treatment (n = 1). One-third (n = 10) received adjuvant chemotherapy. The 1- and 5-year overall survival (OS) in the cohort were 79.2% and 43.3%, respectively. Univariate log-rank testing showed OS varied based on intervention (P < 0.029), sex (P < 0.042), and age (P < 0.025), while on multivariate analysis none of these factors independently predicted OS.

Conclusions: We describe the demographics and presenting features of a national cohort of sinonasal carcinosarcoma patients. Future research is needed to identify predictors of overall survival, and to assess the optimal roles for radiation and systemic chemotherapy.

背景:癌肉瘤是一种罕见的侵袭性恶性肿瘤,可发生在鼻腔和副鼻窦。目前可获得的结果数据有限。因此,我们试图利用国家癌症数据库(NCDB)来描述患者的人口统计学特征和预后:方法:我们对2004年至2016年国家癌症数据库中的鼻窦癌肉瘤患者进行了回顾性分析:结果:共纳入30例患者。患者主要为男性(20 人)、白人(23 人)和私人保险患者(15 人),平均年龄为 62.4 岁。鼻腔是最常见的部位(14 人),其次是上颌窦(8 人)。大多数患者在接受手术治疗后再接受放射治疗(23 人),其余患者仅接受手术治疗(4 人)、放射治疗(2 人)或不接受治疗(1 人)。三分之一的患者(10 人)接受了辅助化疗。组群的1年和5年总生存率(OS)分别为79.2%和43.3%。单变量对数秩检验显示,OS 因干预措施而异(P P P 结论:我们描述了全国鼻窦癌肉瘤患者队列的人口统计学特征和表现特征。未来的研究需要确定总生存期的预测因素,并评估放疗和全身化疗的最佳作用。
{"title":"Carcinosarcoma of the nasal cavity and paranasal sinuses: Review of the national cancer database.","authors":"Jacob C Harris, Jacob G Eide, Rijul S Kshirsagar, Jason A Brant, James N Palmer, Nithin D Adappa","doi":"10.1002/wjo2.82","DOIUrl":"10.1002/wjo2.82","url":null,"abstract":"<p><strong>Background: </strong>Carcinosarcomas are rare, aggressive malignancies that can arise in the nasal cavity and paranasal sinuses. There are limited outcome data available. Accordingly, we sought to use the National Cancer Database (NCDB) to characterize patient demographics and outcomes.</p><p><strong>Method: </strong>A retrospective analysis of the NCDB from 2004 to 2016 for patients with sinonasal carcinosarcoma was conducted.</p><p><strong>Results: </strong>Thirty patients were included. The patients were predominantly male (<i>n</i> = 20), white (<i>n</i> = 23), and privately insured (<i>n</i> = 15), with an average age of 62.4 years. The nasal cavity was the most common subsite (<i>n</i> = 14), followed by the maxillary sinus (<i>n</i> = 8). Most patient were treated with surgery followed by radiation (<i>n</i> = 23), with the remaining undergoing surgery alone (<i>n</i> = 4), radiation alone (<i>n</i> = 2), or no treatment (<i>n</i> = 1). One-third (<i>n</i> = 10) received adjuvant chemotherapy. The 1- and 5-year overall survival (OS) in the cohort were 79.2% and 43.3%, respectively. Univariate log-rank testing showed OS varied based on intervention (<i>P</i> < 0.029), sex (<i>P</i> < 0.042), and age (<i>P</i> < 0.025), while on multivariate analysis none of these factors independently predicted OS.</p><p><strong>Conclusions: </strong>We describe the demographics and presenting features of a national cohort of sinonasal carcinosarcoma patients. Future research is needed to identify predictors of overall survival, and to assess the optimal roles for radiation and systemic chemotherapy.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"115-122"},"PeriodicalIF":0.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/43/3f/WJO2-9-115.PMC10296035.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9714527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-port transoral robotic thyroidectomy without axillary incision: A preliminary report of 20 cases in China. 无腋窝切口的三孔经口机器人甲状腺切除术:中国20例病例的初步报告
Q2 Medicine Pub Date : 2022-10-19 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.83
Bin Zhang, Bikash Rai, Kuang-Yu Fei, Zong-Hui Han, Michelle Savu

Objective: Transoral scarless thyroid surgery has proven to be a popular alternative to traditional approaches. Transoral robotic thyroidectomy (TORT) has been reported using ports on the lower lip and axilla. Avoiding axillary incision can further reduce scars on the armpit. Here, we present our preliminary data from the initial 20 consecutive patients to explore the feasibility of three-port TORT without axillary incision.

Methods: From September 2017 to June 2019, we performed TORT at Beijing United Family Hospital using three intraoral ports without axillary incision via the da Vinci Si system with three robotic arms. The outcomes of the procedure were retrospectively reviewed.

Results: Among 20 patients (mean age 30 ± 7 years; mean tumor size 1.64 ± 0.96 cm), 16 patients underwent unilateral thyroid lobectomy and four had total thyroidectomy with or without central neck dissection. Eighteen patients had papillary thyroid carcinomas (PTC), one had a follicular thyroid carcinoma, and one had a thyroid adenoma. The mean surgical time was 221 ± 68 min. The mean number of retrieved central lymph nodes in the PTC patients was 5.6 ± 5. There was no permanent vocal cord palsy or hypocalcemia postoperatively. One patient had transient vocal cord palsy, which resolved within 1 week. Paresthesia of the lower lip and the chin was observed in nine patients, and one patient had a first-degree burn of the skin flap due to the lens.

Conclusion: Three-port TORT without axillary incision is feasible for selected patients and would be a potential alternative for remote-access thyroid surgery to avoid leaving scars on the neck or the armpit.

目的:经口无疤痕甲状腺手术已被证明是一种替代传统方法的流行手术。有报道称,经口机器人甲状腺切除术(TORT)使用下唇和腋窝的端口。避免腋窝切口可以进一步减少腋窝的疤痕。在此,我们展示了最初20例连续患者的初步数据,以探讨无腋窝切口的三孔TORT的可行性:2017年9月至2019年6月,我们在北京和睦家医院通过达芬奇Si系统的三个机械臂,使用口内三孔无腋窝切口进行了TORT手术。对手术结果进行了回顾性分析:20名患者(平均年龄为30±7岁;平均肿瘤大小为1.64±0.96厘米)中,16名患者接受了单侧甲状腺叶切除术,4名患者接受了带或不带颈部中央切除术的全甲状腺切除术。18名患者患有甲状腺乳头状癌(PTC),1名患者患有甲状腺滤泡状癌,1名患者患有甲状腺腺瘤。平均手术时间为 221 ± 68 分钟。PTC患者取回的中央淋巴结平均数目为5.6 ± 5。术后没有出现永久性声带麻痹或低钙血症。一名患者出现一过性声带麻痹,在一周内缓解。九名患者的下唇和下巴出现麻痹,一名患者的皮瓣被镜头造成一级烧伤:结论:不经腋窝切口的三孔甲状腺切除术对特定患者是可行的,也是远处入路甲状腺手术的潜在替代方案,可避免在颈部或腋窝留下疤痕。
{"title":"Three-port transoral robotic thyroidectomy without axillary incision: A preliminary report of 20 cases in China.","authors":"Bin Zhang, Bikash Rai, Kuang-Yu Fei, Zong-Hui Han, Michelle Savu","doi":"10.1002/wjo2.83","DOIUrl":"10.1002/wjo2.83","url":null,"abstract":"<p><strong>Objective: </strong>Transoral scarless thyroid surgery has proven to be a popular alternative to traditional approaches. Transoral robotic thyroidectomy (TORT) has been reported using ports on the lower lip and axilla. Avoiding axillary incision can further reduce scars on the armpit. Here, we present our preliminary data from the initial 20 consecutive patients to explore the feasibility of three-port TORT without axillary incision.</p><p><strong>Methods: </strong>From September 2017 to June 2019, we performed TORT at Beijing United Family Hospital using three intraoral ports without axillary incision via the da Vinci Si system with three robotic arms. The outcomes of the procedure were retrospectively reviewed.</p><p><strong>Results: </strong>Among 20 patients (mean age 30 ± 7 years; mean tumor size 1.64 ± 0.96 cm), 16 patients underwent unilateral thyroid lobectomy and four had total thyroidectomy with or without central neck dissection. Eighteen patients had papillary thyroid carcinomas (PTC), one had a follicular thyroid carcinoma, and one had a thyroid adenoma. The mean surgical time was 221 ± 68 min. The mean number of retrieved central lymph nodes in the PTC patients was 5.6 ± 5. There was no permanent vocal cord palsy or hypocalcemia postoperatively. One patient had transient vocal cord palsy, which resolved within 1 week. Paresthesia of the lower lip and the chin was observed in nine patients, and one patient had a first-degree burn of the skin flap due to the lens.</p><p><strong>Conclusion: </strong>Three-port TORT without axillary incision is feasible for selected patients and would be a potential alternative for remote-access thyroid surgery to avoid leaving scars on the neck or the armpit.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"138-143"},"PeriodicalIF":0.0,"publicationDate":"2022-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b7/cc/WJO2-9-138.PMC10296045.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10112934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A proposed association between subjective nonpulsatile tinnitus and migraine. 主观性非脉冲性耳鸣与偏头痛之间的关联。
Q2 Medicine Pub Date : 2022-10-13 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.81
Ariel Lee, Mehdi Abouzari, Meleeka Akbarpour, Adwight Risbud, Harrison W Lin, Hamid R Djalilian

Objective: Tinnitus is defined as the perception of sound in the absence of an external source. We propose the hypothesis that migraine can cause exacerbation of tinnitus in some patients.

Methods: English literature from PubMed has been reviewed.

Results: Studies have reported a high prevalence of cochlear symptoms in patients with migraine headaches and up to 45% of tinnitus patients have been shown to concomitantly suffer from migraine. Both conditions are thought to stem from central nervous system disturbances, involving disruption of the auditory and trigeminal nerve pathways. One proposed mechanism of this association is the modulation of sound sensitivity by trigeminal nerve activation of the auditory cortex during migraine attacks, resulting in tinnitus fluctuation in some patients. Increased brain and inner ear vascular permeability resulting from trigeminal nerve inflammation, can also cause observed headache and auditory symptoms. Tinnitus and migraine also share a number of symptom triggers including stress, sleep disturbances, and dietary factors. These shared features may help explain promising results of migraine therapies for the treatment of tinnitus.

Conclusion: Given the complex association between tinnitus and migraine, further investigation is needed to identify the underlying mechanisms and determine the optimal treatment strategies for managing migraine-related tinnitus patients.

目的:耳鸣是指在没有外部声源的情况下对声音的感知。我们提出了偏头痛可导致部分患者耳鸣加剧的假设:方法:我们查阅了 PubMed 上的英文文献:研究报告显示,偏头痛患者耳蜗症状的发生率很高,高达 45% 的耳鸣患者同时患有偏头痛。这两种病症都被认为源于中枢神经系统紊乱,涉及听觉和三叉神经通路的破坏。这种关联的一种机制是,偏头痛发作时,三叉神经激活听觉皮层,从而调节声音的敏感度,导致一些患者耳鸣波动。三叉神经炎症导致的大脑和内耳血管通透性增加,也会引起观察到的头痛和听觉症状。耳鸣和偏头痛还有一些共同的症状诱因,包括压力、睡眠障碍和饮食因素。这些共同特征可能有助于解释偏头痛疗法治疗耳鸣的良好效果:鉴于耳鸣与偏头痛之间的复杂关联,需要进一步调查以确定其潜在机制,并确定管理偏头痛相关耳鸣患者的最佳治疗策略。
{"title":"A proposed association between subjective nonpulsatile tinnitus and migraine.","authors":"Ariel Lee, Mehdi Abouzari, Meleeka Akbarpour, Adwight Risbud, Harrison W Lin, Hamid R Djalilian","doi":"10.1002/wjo2.81","DOIUrl":"10.1002/wjo2.81","url":null,"abstract":"<p><strong>Objective: </strong>Tinnitus is defined as the perception of sound in the absence of an external source. We propose the hypothesis that migraine can cause exacerbation of tinnitus in some patients.</p><p><strong>Methods: </strong>English literature from PubMed has been reviewed.</p><p><strong>Results: </strong>Studies have reported a high prevalence of cochlear symptoms in patients with migraine headaches and up to 45% of tinnitus patients have been shown to concomitantly suffer from migraine. Both conditions are thought to stem from central nervous system disturbances, involving disruption of the auditory and trigeminal nerve pathways. One proposed mechanism of this association is the modulation of sound sensitivity by trigeminal nerve activation of the auditory cortex during migraine attacks, resulting in tinnitus fluctuation in some patients. Increased brain and inner ear vascular permeability resulting from trigeminal nerve inflammation, can also cause observed headache and auditory symptoms. Tinnitus and migraine also share a number of symptom triggers including stress, sleep disturbances, and dietary factors. These shared features may help explain promising results of migraine therapies for the treatment of tinnitus.</p><p><strong>Conclusion: </strong>Given the complex association between tinnitus and migraine, further investigation is needed to identify the underlying mechanisms and determine the optimal treatment strategies for managing migraine-related tinnitus patients.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"107-114"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f8/e7/WJO2-9-107.PMC10296047.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in otolaryngology application requirements and match outcomes: Are we doing any better? 耳鼻喉科申请要求和匹配结果的变化:我们做得更好吗?
Q2 Medicine Pub Date : 2022-10-02 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.79
Emma De Ravin, Ariel S Frost, Neal R Godse, Amber D Shaffer, Noel Jabbour, Barry M Schaitkin, Jason Newman, Leila J Mady

Objectives: Otolaryngology-specific requirements were piloted to minimize applicant and program burdens. We investigated the impact of introducing and then removing these requirements on Match outcomes.

Methods: 2014-2021 National Resident Matching Program® data were examined. The primary outcome was the impact of Otolaryngology Resident Talent Assessment (ORTA; prematch 2017, postmatch 2019) and Program-Specific Paragraph (PSP; implemented 2016, optional 2018) on applicant numbers and match rates. Secondary survey analysis assessed candidate perceptions of PSP/ORTA.

Results: Applicant numbers declined significantly during PSP/ORTA (18.9%; p = 0.001). With the optional PSP and postmatch ORTA, applicant numbers increased significantly (39.0%; p = 0.002). Examined individually, mandatory PSP was associated with a significant decline in applicants (p = 0.007), whereas postmatch ORTA was associated with significant increases in applicants (p = 0.010). ORTA and PSP negatively impacted the decision to apply to otolaryngology in 59.8% and 51.3% of applicants, respectively. Conversely, match rate success improved significantly from 74.8% to 91.2% during PSP/ORTA (p = 0.014), followed by a significant decline to 73.1% after PSP was made optional and ORTA moved to postmatch (p = 0.002).

Conclusions: ORTA and PSP correlated with decreased applicant numbers and increased match rate success. As programs seek ways to remove barriers to applying to otolaryngology, the potential consequences of an increasing pool of unmatched candidates must also be considered.

目标:试行耳鼻喉科特定要求,以尽量减轻申请人和项目的负担。我们研究了引入和取消这些要求对匹配结果的影响。方法:研究了 2014-2021 年国家驻地匹配计划® 的数据。主要结果是耳鼻喉科住院医师人才评估(ORTA;2017 年预匹配,2019 年后匹配)和特定项目段(PSP;2016 年实施,2018 年可选)对申请人数量和匹配率的影响。二次调查分析评估了候选人对PSP/ORTA的看法:在 PSP/ORTA 期间,申请人数大幅下降(18.9%;p = 0.001)。通过可选的 PSP 和匹配后 ORTA,申请人数大幅增加(39.0%;p = 0.002)。单独来看,强制性 PSP 与申请人数大幅减少有关(p = 0.007),而匹配后 ORTA 则与申请人数大幅增加有关(p = 0.010)。ORTA和PSP分别对59.8%和51.3%的申请人申请耳鼻喉科的决定产生了负面影响。相反,在PSP/ORTA期间,匹配成功率从74.8%大幅提高到91.2%(p = 0.014),在PSP成为可选项和ORTA转为匹配后,匹配成功率大幅下降到73.1%(p = 0.002):结论:ORTA 和 PSP 与申请人数量减少和匹配成功率提高相关。结论:ORTA 和 PSP 与申请人数的减少和匹配成功率的提高相关。当项目寻求各种方法来消除申请耳鼻喉科的障碍时,还必须考虑未匹配考生人数增加的潜在后果。
{"title":"Changes in otolaryngology application requirements and match outcomes: Are we doing any better?","authors":"Emma De Ravin, Ariel S Frost, Neal R Godse, Amber D Shaffer, Noel Jabbour, Barry M Schaitkin, Jason Newman, Leila J Mady","doi":"10.1002/wjo2.79","DOIUrl":"10.1002/wjo2.79","url":null,"abstract":"<p><strong>Objectives: </strong>Otolaryngology-specific requirements were piloted to minimize applicant and program burdens. We investigated the impact of introducing and then removing these requirements on Match outcomes.</p><p><strong>Methods: </strong>2014-2021 National Resident Matching Program® data were examined. The primary outcome was the impact of Otolaryngology Resident Talent Assessment (ORTA; prematch 2017, postmatch 2019) and Program-Specific Paragraph (PSP; implemented 2016, optional 2018) on applicant numbers and match rates. Secondary survey analysis assessed candidate perceptions of PSP/ORTA.</p><p><strong>Results: </strong>Applicant numbers declined significantly during PSP/ORTA (18.9%; <i>p</i> = 0.001). With the optional PSP and postmatch ORTA, applicant numbers increased significantly (39.0%; <i>p</i> = 0.002). Examined individually, mandatory PSP was associated with a significant decline in applicants (<i>p</i> = 0.007), whereas postmatch ORTA was associated with significant increases in applicants (<i>p</i> = 0.010). ORTA and PSP negatively impacted the decision to apply to otolaryngology in 59.8% and 51.3% of applicants, respectively. Conversely, match rate success improved significantly from 74.8% to 91.2% during PSP/ORTA (<i>p</i> = 0.014), followed by a significant decline to 73.1% after PSP was made optional and ORTA moved to postmatch (<i>p</i> = 0.002).</p><p><strong>Conclusions: </strong>ORTA and PSP correlated with decreased applicant numbers and increased match rate success. As programs seek ways to remove barriers to applying to otolaryngology, the potential consequences of an increasing pool of unmatched candidates must also be considered.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"144-152"},"PeriodicalIF":0.0,"publicationDate":"2022-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9714526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
World Journal of OtorhinolaryngologyHead and Neck Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1